The new Secura laboratory balance developed for applications in regulated areas such as pharmaceutical labs fulfills particularly high reliability requirements. The balance monitors its ambient conditions automatically, thereby preventing handling errors.
Abbott Laboratories said Friday that it plans to buy back up to $3 billion of its common stock, replacing a finished $5 billion program that began before the health care company separated from its drug business. Abbott makes generic drugs, medical implants and nutritional formula. It spun off its...
The cellVivo incubation system is used for precise and ergonomic environmental control of advanced live cell imaging. Following the modular approach of the IX3 range of inverted microscope frames, cellVivo is based on a "one size fits all" concept, with adaptors for various IX73 and IX83 frame types, circumventing the need for multiple incubation systems for distinct microscope configurations.
The metering pump is available in bare shaft, close-coupled and motorized configurations, each delivering smooth, metered flow free from pulsations and variations to prevent material waste or mixture imbalance.
There is an all-new FLEXI-DISC™ line of tubular cable conveyors for the gentle transfer of non-food products. The conveyor moves material using high-strength polymer discs — affixed to a stainless steel or galvanized cable — that slide within smooth stainless steel tubing, moving fragile products gently, quietly and dust-free, horizontally, vertically or at any angle, through small holes in walls or ceilings.
Items in the low-cost ProGrade® series of magnetic separators from Eriez® are available at three different degrees of magnetic strength, enabling professionals in diverse industries to choose the ideal level of protection for their specific application.
The Protect-O-Gate "clear-aisle" mezzanine safety gate features a revolutionary design that requires only 10 inches of floor space when closed at the mezzanine ledge. The "clear-aisle" safety gate features a double-gate design and three-sided load access to ensure constant fall protection in the tightest spaces without sacrificing productivity.
Dr. Vidadi Yusibov, Executive Director of the Fraunhofer USA Center for Molecular Biotechnology (CMB), has received international recognition for development of the Center’s plant-based protein expression technology that lead to the construction of first in-its-kind good manufacturing practices (GMP) compliant automated bio-manufacturing plant.
The Food and Drug Administration is proposing new regulations to require medical device makers to guard against cyber attacks. Even though there have been no cases thus far of “hacking” medical devices – the FDA wants companies to be prepared for this eventuality.
The 10-year-old Pennsylvania girl who fought for a lung transplant has a difficult journey ahead. The transplant isn't a cure for her cystic fibrosis, and new lungs don't tend to last as long as other transplanted organs. But it can extend life by years, buying some time.
A suburban Indianapolis city has filed a foreclosure lawsuit against a pharmaceutical company that failed to open after receiving $8.4 million in loans and other assistance from the city. Greenwood officials had tried for months to help with talks involving possible investors in hopes of saving Elona Biotechnologies before deciding to file the lawsuit, Mayor Mark Myers said.
Amgen Inc. said yesterday that the Food and Drug Administration has approved a new use for its bone drug Xgeva. The company, based in Thousand Oaks, Calif., said it now can market Xgeva for treating a rare condition, giant cell tumor of bone, when surgery isn't practical.
Bristol-Myers Squibb and Simcere Enter Partnership to Co-Develop and Co-Commercialize Orencia(R) SC (abatacept) in ChinaJune 14, 2013 8:25 am | News | Comments
Bristol-Myers Squibb Company and Simcere Pharmaceutical Group, a leading pharmaceutical company in China, today announced that the companies have expanded their strategic relationship formed in 2010. The companies have agreed to collaborate in China on the development and commercialization of the subcutaneous (SC) formulation of Bristol-Myers Squibb's biologic medicine, Orencia, for the treatment of rheumatoid arthritis.
Eli Lilly and Co. said Thursday that it stopped a mid-stage clinical trial of an experimental Alzheimer's disease drug because of potential side effects on patients' livers. The company stopped testing LY2886721 because of abnormal results in liver biochemical tests. Lilly says the results were...